News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Daily News Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD Yael L. Maxwell November 21, 2022
News Daily News Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status Todd Neale August 19, 2022
News Daily News Heavy Calcification Levels PCI/CABG Playing Field at 10 Years: SYNTAXES Yael L. Maxwell January 06, 2022
News Daily News De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis Yael L. Maxwell July 16, 2021
News Daily News ‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests Michael O'Riordan September 18, 2020
News Daily News P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention Yael L. Maxwell May 15, 2020
News Daily News Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS Caitlin E. Cox September 20, 2019
News Daily News Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests L.A. McKeown January 08, 2019
News Daily News CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition Michael O'Riordan August 04, 2017
News Daily News Anemia Common in ACS Patients, Linked with Higher Mortality Michael O'Riordan November 23, 2016
News Daily News Los Pacientes SLF con Hemorragias Post-Alta Hospitalaria Corren un Mayor Riesgo de Mortalidad Todd Neale August 31, 2015
News Daily News DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk Todd Neale August 31, 2015
News Daily News Un Estudio Explora el Uso en el ‘Mundo Real’ de Prasugrel vs. Clopidogrel en el Manejo del SCA May 12, 2015